Skip to content

Research at St Andrews

Perspectives for systems biology in the management of tuberculosis

Research output: Contribution to journalReview articlepeer-review

Author(s)

I. Kontsevaya, C. Lange, P. Comella-Del-Barrio, C. Coarfa, A.R. DiNardo, S.H. Gillespie, M. Hauptmann, C. Leschczyk, A.M. Mandalakas, A. Martinecz, M. Merker, S. Niemann, M. Reimann, O. Rzhepishevska, U.E. Schaible, K.M. Scheu, E. Schurr, P. Abel Zur Wiesch, J. Heyckendorf

School/Research organisations

Abstract

Standardised management of tuberculosis may soon be replaced by individualised, precision medicine-guided therapies informed with knowledge provided by the field of systems biology. Systems biology is a rapidly expanding field of computational and mathematical analysis and modelling of complex biological systems that can provide insights into mechanisms underlying tuberculosis, identify novel biomarkers, and help to optimise prevention, diagnosis and treatment of disease. These advances are critically important in the context of the evolving epidemic of drug-resistant tuberculosis. Here, we review the available evidence on the role of systems biology approaches - human and mycobacterial genomics and transcriptomics, proteomics, lipidomics/metabolomics, immunophenotyping, systems pharmacology and gut microbiomes - in the management of tuberculosis including prediction of risk for disease progression, severity of mycobacterial virulence and drug resistance, adverse events, comorbidities, response to therapy and treatment outcomes. Application of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach demonstrated that at present most of the studies provide "very low" certainty of evidence for answering clinically relevant questions. Further studies in large prospective cohorts of patients, including randomised clinical trials, are necessary to assess the applicability of the findings in tuberculosis prevention and more efficient clinical management of patients.
Close

Details

Original languageEnglish
Article number200377
Number of pages16
JournalEuropean Respiratory Review
Volume30
Issue number160
Early online date25 May 2021
DOIs
Publication statusPublished - 30 Jun 2021

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low- and middle- income country setting

    Ntinginya, N. E., Kuchaka, D., Orina, F., Mwebaza, I., Liyoyo, A., Miheso, B., Aturinde, A., Njeleka, F., Kiula, K., Msoka, E. F., Meme, H., Sanga, E., Mwanyonga, S., Olomi, W., Minja, L., Joloba, M., Mmbaga, B. T., Amukoye, E., Gillespie, S. H. & Sabiiti, W., 24 Aug 2021, In: BMJ Global Health. 6, 8, 12 p., e005357.

    Research output: Contribution to journalArticlepeer-review

  2. Qualitative assessment of the impact of socioeconomic and cultural barriers on uptake and utilisation of tuberculosis diagnostic and treatment tools in East Africa: a cross-sectional study

    Msoka, E. F., Orina, F., Sanga, E., Miheso, B., Mwanyonga, S., Meme, H., Kiula, K., Liyoyo, A., Mwebaza, I., Aturinde, A., Joloba, M., Mmbaga, B. T., Amukoye, E., Ntinginya, N. E., Gillespie, S. H. & Sabiiti, W., 12 Jul 2021, In: BMJ Open. 11, 7, 9 p., e050911.

    Research output: Contribution to journalArticlepeer-review

  3. Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment

    Thanh Hai, H., Sabiiti, W., Anh Thu, D. D., Hoan Phu, N., Gillespie, S. H., Thwaites, G. & Thuy Thuong Thuong, N., May 2021, In: Tuberculosis. 128, 6 p., 102084.

    Research output: Contribution to journalArticlepeer-review

  4. A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

    Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y. L., Bateson, A. L. C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S. M., Hunt, R., Ismail, A. I. & 19 others, Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M. & Gillespie, S. H., 1 Apr 2021, In: International Journal of Tuberculosis and Lung Disease. 25, 4, p. 305-314 10 p.

    Research output: Contribution to journalArticlepeer-review

  5. Mycobactericidal effect of different regimens measured by molecular bacterial load assay among people treated for multidrug-resistant tuberculosis in Tanzania

    Mbelele, P. M., Mpolya, E. A., Sauli, E., Mtafya, B., Ntinginya, N. E., Addo, K. K., Kreppel, K., Mfinanga, S., Phillips, P. P. J., Gillespie, S. H., Heysell, S. K., Sabiiti, W. & Mpagama, S. G., 19 Mar 2021, In: Journal of Clinical Microbiology. 59, 4, 12 p., e02927-20.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. The role of moxifloxacin in tuberculosis therapy

    Gillespie, S. H., Mar 2016, In: European Respiratory Review. 25, 139, p. 19-28 10 p.

    Research output: Contribution to journalArticlepeer-review

ID: 274588623

Top